232 related articles for article (PubMed ID: 26598040)
21. Prognosis in advanced lung cancer--A prospective study examining key clinicopathological factors.
Simmons CP; Koinis F; Fallon MT; Fearon KC; Bowden J; Solheim TS; Gronberg BH; McMillan DC; Gioulbasanis I; Laird BJ
Lung Cancer; 2015 Jun; 88(3):304-9. PubMed ID: 25870155
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer.
Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K
Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
24. Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.
Lv Y; Pan Y; Dong C; Liu P; Zhang C; Xing D
Med Sci Monit; 2017 Aug; 23():3780-3788. PubMed ID: 28775246
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer.
Inoue Y; Iwata T; Okugawa Y; Kawamoto A; Hiro J; Toiyama Y; Tanaka K; Uchida K; Mohri Y; Miki C; Kusunoki M
Oncology; 2013; 84(2):100-7. PubMed ID: 23147449
[TBL] [Abstract][Full Text] [Related]
27. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
28. Inflammation-based prognostic score predicts biliary stent patency in patients with unresectable malignant biliary obstruction.
Iwasaki Y; Ishizuka M; Kato M; Kita J; Shimoda M; Kubota K
Anticancer Res; 2014 Jul; 34(7):3617-22. PubMed ID: 24982377
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment Modified Glasgow Prognostic Score Predicts Clinical Outcomes After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
Kishi T; Matsuo Y; Ueki N; Iizuka Y; Nakamura A; Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):619-26. PubMed ID: 26068494
[TBL] [Abstract][Full Text] [Related]
30. A systemic inflammation-based prognostic scores (mGPS) predicts overall survival of patients with small-cell lung cancer.
Zhou T; Hong S; Hu Z; Hou X; Huang Y; Zhao H; Liang W; Zhao Y; Fang W; Wu X; Qin T; Zhang L
Tumour Biol; 2015 Jan; 36(1):337-43. PubMed ID: 25256672
[TBL] [Abstract][Full Text] [Related]
31. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
[TBL] [Abstract][Full Text] [Related]
32. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
33. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer.
Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y
Oncology; 2014; 87(4):205-14. PubMed ID: 25034097
[TBL] [Abstract][Full Text] [Related]
34. Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score.
Draeger DL; Groh S; Buchholz T; Woehl M; Nolting J; Hakenberg OW
Urol Int; 2023; 107(5):489-495. PubMed ID: 34610603
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
[TBL] [Abstract][Full Text] [Related]
36. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
37. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
Wu M; Guo J; Guo L; Zuo Q
Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157
[TBL] [Abstract][Full Text] [Related]
38. The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer.
Knight K; Choong JX; McKee RF; Anderson JH; Horgan PG; McMillan DC; McDonald A; Roxburgh CS
Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e22-e30. PubMed ID: 32709540
[TBL] [Abstract][Full Text] [Related]
39. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
[TBL] [Abstract][Full Text] [Related]
40. Modified Glasgow prognostic score can predict survival of muscle invasive bladder cancer patients after radiotherapy.
Kikuchi K; Nakamura R; Segawa T; Oikawa H; Ariga H
J Radiat Res; 2020 Jul; 61(4):616-621. PubMed ID: 32567660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
